{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:55:56Z","timestamp":1790178956306,"version":"4.1.0"},"reference-count":32,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2014.00502","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T10:40:22Z","timestamp":1413283222000},"source":"Crossref","is-referenced-by-count":5,"title":["Erythropoietin Combined with Liposomal Amphotericin B Improves Outcome during Disseminated Aspergillosis in Mice"],"prefix":"10.3389","volume":"5","author":[{"given":"Nathalie","family":"Rousseau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Picot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Lise","family":"Bienvenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,10,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/cid\/ciu337","article-title":"Immune correlates of protection in human invasive aspergillosis","volume":"59","author":"Camargo","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1469-0691.2009.02929.x","article-title":"Trends in invasive fungal infections, with emphasis on invasive aspergillosis","volume":"15","author":"Erjavec","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"B3","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/QCO.0000000000000043","article-title":"Approach to invasive pulmonary aspergillosis in critically ill patients","volume":"27","author":"Koulenti","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.drudis.2008.11.013","article-title":"Targeting virulence: a new paradigm for antifungals","volume":"14","author":"Gauwerky","year":"2009","journal-title":"Drug Discov Today"},{"key":"B6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1462-5822.2008.01247.x","article-title":"Polarized response of endothelial cells to invasion by Aspergillus fumigatus","volume":"11","author":"Kamai","year":"2009","journal-title":"Cell Microbiol"},{"issue":"Suppl 1","key":"B7","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1080\/13693780600897989","article-title":"Interactions of Aspergillus fumigatus with vascular endothelial cells","volume":"44","author":"Kamai","year":"2006","journal-title":"Med Mycol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.2217\/fmb.13.114","article-title":"Angiogenesis at the mold-host interface: a potential key to understanding and treating invasive aspergillosis","volume":"8","author":"Ben-Ami","year":"2013","journal-title":"Future Microbiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1128\/CMR.00055-08","article-title":"Pathogenesis of Aspergillus fumigatus in invasive aspergillosis","volume":"22","author":"Dagenais","year":"2009","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 1","key":"B10","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1038\/sj.cdd.4401450","article-title":"Erythropoietin as an antiapoptotic, tissue-protective cytokine","volume":"11","author":"Ghezzi","year":"2004","journal-title":"Cell Death Differ"},{"key":"B11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1084\/jem.20122760","article-title":"Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration","volume":"210","author":"Broxmeyer","year":"2013","journal-title":"J Exp Med"},{"issue":"4","key":"B12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/SHK.0000000000000216","article-title":"Erythropoietin promotes the protective properties of transplanted endothelial progenitor cells against acute lung injury via PI3K\/Akt pathway","volume":"42","author":"Hu","year":"2014","journal-title":"Shock"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e29893","DOI":"10.1371\/journal.pone.0029893","article-title":"Effects of continuous erythropoietin receptor activator in sepsis-induced acute kidney injury and multi-organ dysfunction","volume":"7","author":"Rodrigues","year":"2012","journal-title":"PLoS One"},{"key":"B14","first-page":"321","article-title":"Evaluation of the effects of a high dose of erythropoietin-beta on early endotoxemia using a rat model","volume":"21","author":"Eren","year":"2012","journal-title":"Adv Clin Exp Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1995-7645(14)60087-0","article-title":"Tissue tropism and parasite burden of Toxoplasma gondii RH strain in experimentally infected mice","volume":"7","author":"Dadimoghaddam","year":"2014","journal-title":"Asian Pac J Trop Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1297-9716-45-63","article-title":"Neonatal influenza infection causes pathological changes in the mouse brain","volume":"45","author":"Yu","year":"2014","journal-title":"Vet Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu372","article-title":"An animal model of a newly emerging human ehrlichiosis","author":"Saito","year":"2014","journal-title":"J Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.actatropica.2008.02.001","article-title":"Artesunate-erythropoietin combination for murine cerebral malaria treatment","volume":"106","author":"Bienvenu","year":"2008","journal-title":"Acta Trop"},{"key":"B20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/978-1-62703-308-4_19","article-title":"Cerebral malaria: protection by erythropoietin","volume":"982","author":"Bienvenu","year":"2013","journal-title":"Methods Mol Biol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/1475-2875-8-169","article-title":"Safety of epoietin beta-quinine drug combination in children with cerebral malaria in Mali","volume":"8","author":"Picot","year":"2009","journal-title":"Malar J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1053\/jinf.2000.0744","article-title":"Fatal haemoptysis induced by invasive pulmonary aspergillosis in patients with acute leukaemia during bone marrow and clinical remission: report of two cases and review of the literature","volume":"41","author":"Gorelik","year":"2000","journal-title":"J Infect"},{"key":"B23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1365-2796.2008.02024.x","article-title":"Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response","volume":"264","author":"Brines","year":"2008","journal-title":"J Intern Med"},{"issue":"Suppl 1","key":"B24","doi-asserted-by":"publisher","first-page":"i41","DOI":"10.1093\/jac\/dkm426","article-title":"Salvage therapy for invasive aspergillosis","volume":"61","author":"Dockrell","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e1002401","DOI":"10.1371\/journal.ppat.1002401","article-title":"Participants of the Hinxton retreat meeting on animal models for research on severe malaria. The role of animal models for research on severe malaria","volume":"8","author":"Craig","year":"2012","journal-title":"PLoS Pathog"},{"issue":"9","key":"B26","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.drudis.2014.06.006","article-title":"Animal models of invasive aspergillosis for drug discovery","volume":"19","author":"Paulussen","year":"2014","journal-title":"Drug Discov Today"},{"key":"B27","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/aps.2009.83","article-title":"NAC is associated with additional alleviation of lung injury induced by invasive pulmonary aspergillosis in a neutropenic model","volume":"30","author":"Xu","year":"2009","journal-title":"Acta Pharmacol Sin"},{"issue":"9","key":"B28","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/labinvest.2014.84","article-title":"Erythropoietin protects against hemorrhagic blood-brain barrier disruption through the effects of aquaporin-4","volume":"94","author":"Chu","year":"2014","journal-title":"Lab Invest"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1038\/sj.bjc.6605255","article-title":"Epoetin-beta treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events","volume":"101","author":"Aapro","year":"2009","journal-title":"Br J Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(03)14567-9","article-title":"Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial","volume":"362","author":"Henke","year":"2003","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N Engl J Med"},{"key":"B32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03402029","article-title":"Erythropoietin therapy for acute stroke is both safe and beneficial","volume":"8","author":"Ehrenreich","year":"2002","journal-title":"Mol Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T01:26:18Z","timestamp":1565918778000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2014.00502\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,14]]},"references-count":32,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2014.00502","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,14]]}}}